Utah Valley Pediatrics L.L.C.

Utah Valley Pediatrics L.L.C. was paid $11.95M by Medicaid between Jan 2018 and Dec 2024, across 114 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 52% of everything it billed.

33Billing provider infoUTAH VALLEY PEDIATRICS L.L.C.
PROVO, UT 84604

33aNPI1497812721assigned 01/03/2007

33bProvider typePediatrics Physician

28Total paid$11.95M

24GClaims453,580

24DCodes billed114

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pediatrics Physician providers in Utah

Rank by total paid#1 of 299

Median peer was paid$16K

This provider vs. median738×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	19,801	$732K
2019	20,271	$735K
2020	22,009	$602K
2021	83,434	$2.56M
2022	87,999	$3.07M
2023	113,903	$2.17M
2024incomplete	106,163	$2.08M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	52%	96,111	87,317	$6.24M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	13%	22,725	20,261	$1.54M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	10%	14,815	13,795	$1.21M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	9.9%	17,618	17,394	$1.18M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	3.3%	8,269	8,183	$389K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	2.0%	10,364	9,886	$235K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	1.2%	47,364	45,780	$143K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	4,025	3,976	$109K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	37,891	33,045	$79K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,788	1,743	$73K
99051		<1%	16,407	15,482	$72K
99460		<1%	1,033	1,027	$69K

102 more codes

90461		<1%	4,697	$61K
99238	Hospital discharge day management, 30 minutes or less	<1%	996	$55K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,915	$49K
90472	Immunization administration, each additional vaccine (list separately)	<1%	21,369	$49K
90686		<1%	13,803	$41K
99203	Doctor's office visit, new patient (routine)	<1%	439	$33K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	5,727	$31K
91307		<1%	818	$24K
17110		<1%	375	$23K
99381		<1%	464	$23K
96127		<1%	14,252	$22K
99463		<1%	261	$21K
99383		<1%	321	$15K
90474		<1%	4,623	$13K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	326	$11K
99382		<1%	232	$11K
99177		<1%	18,289	$11K
99188		<1%	3,935	$9K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,009	$8K
99493		<1%	729	$7K
87634		<1%	156	$7K
91308		<1%	197	$7K
99462		<1%	211	$6K
36416		<1%	3,695	$5K
99492		<1%	357	$4K
91300		<1%	132	$4K
90473		<1%	1,190	$4K
96161		<1%	10,710	$4K
99215	Doctor's office visit, returning patient (complex)	<1%	31	$3K
90670		<1%	6,381	$3K
90672		<1%	1,138	$2K
91320		<1%	142	$2K
90698		<1%	3,979	$2K
99173		<1%	2,870	$2K
0071A		<1%	335	$2K
81002		<1%	823	$2K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	109	$2K
81003		<1%	942	$2K
90480		<1%	587	$2K
90656		<1%	1,977	$2K
0173A		<1%	57	$2K
99384		<1%	68	$2K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,330	$2K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	576	$2K
90697		<1%	5,894	$1K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	102	$1K
0124A		<1%	55	$1K
99494		<1%	202	$1K
0154A		<1%	33	$1K
85018		<1%	1,176	$1K
0072A		<1%	212	$1K
90680		<1%	6,733	$952.52
83655		<1%	949	$917.96
94010		<1%	177	$888.26
90633		<1%	3,593	$851.96
G0312	Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)	<1%	76	$851.75
96381		<1%	211	$709.13
90620		<1%	712	$631.56
90651		<1%	1,935	$550.02
90671		<1%	5,575	$499.75
91312		<1%	55	$475.32
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	418	$431.87
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	67	$317.38
85013		<1%	588	$313.44
90716		<1%	1,183	$308.16
90707		<1%	1,215	$305.92
80061	Lipid panel	<1%	69	$291.07
90710		<1%	1,597	$270.15
90744		<1%	550	$182.37
90715		<1%	1,080	$149.96
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	37	$141.03
J8540	Dexamethasone, oral, 0.25 mg	<1%	74	$139.59
87086	Culture, bacterial; quantitative colony count, urine	<1%	25	$127.06
91318		<1%	223	$121.27
82947		<1%	32	$114.63
90660		<1%	398	$114.25
82948		<1%	73	$106.32
96380		<1%	81	$102.49
90685		<1%	262	$86.41
36415	Collection of venous blood by venipuncture	<1%	24	$67.14
90696		<1%	1,235	$59.39
0081A		<1%	42	$40.00
96160		<1%	432	$22.91
A7003	Administration set, with small volume nonfiltered pneumatic nebulizer, disposable	<1%	216	$12.53
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	195	$9.77
A7015	Aerosol mask, used with dme nebulizer	<1%	157	$7.91
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	132	$7.76
90619		<1%	1,505	$0.01
90700		0%	207	$0.00
90734		0%	26	$0.00
90380		0%	94	$0.00
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	0%	82	$0.00
90713		0%	27	$0.00
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	0%	35	$0.00
0002A		0%	19	$0.00
90648		0%	13	$0.00
91319		0%	156	$0.00
90381		0%	192	$0.00
0001A		0%	37	$0.00
91317		0%	59	$0.00
90378		0%	14	$0.00
91315		0%	36	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOFFITT, KEVIN (ADMINISTRATOR)